Tamoxifen Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

ETHAN - ET for Male BC
Conditions:   Male Breast Cancer;   Hormone Receptor-positive Breast Cancer;   Hormone Receptor Negative Breast Carcinoma Interventions:   Drug: Tamoxifen;   Drug: Anastrozole;   Drug: Degarelix;   Drug: Abemaciclib Sponsors:   Jose Pablo Leone;   Eli Lilly and Company;   Translational Breast Cancer Research Consortium (TBCRC) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 15, 2022 Category: Research Source Type: clinical trials

CYP2D6 Genotypes and Breast Cancer Clinical Outcomes in the Indonesian Population
Condition:   Breast Cancer Intervention:   Drug: Tamoxifen Sponsors:   Nalagenetics Pte Ltd;   SJH Initiatives;   Fakultas Farmasi Universitas Indonesia;   MRCCC Siloam Hospitals Semanggi Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 15, 2022 Category: Research Source Type: clinical trials

ETHAN - ET for Male BC
Conditions:   Male Breast Cancer;   Hormone Receptor-positive Breast Cancer;   Hormone Receptor Negative Breast Carcinoma Interventions:   Drug: Tamoxifen;   Drug: Anastrozole;   Drug: Degarelix;   Drug: Abemaciclib Sponsors:   Jose Pablo Leone;   Eli Lilly and Company;   Translational Breast Cancer Research Consortium (TBCRC) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 15, 2022 Category: Research Source Type: clinical trials

CYP2D6 Genotypes and Breast Cancer Clinical Outcomes in the Indonesian Population
Condition:   Breast Cancer Intervention:   Drug: Tamoxifen Sponsors:   Nalagenetics Pte Ltd;   SJH Initiatives;   Fakultas Farmasi Universitas Indonesia;   MRCCC Siloam Hospitals Semanggi Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 15, 2022 Category: Research Source Type: clinical trials

ETHAN - ET for Male BC
Conditions:   Male Breast Cancer;   Hormone Receptor-positive Breast Cancer;   Hormone Receptor Negative Breast Carcinoma Interventions:   Drug: Tamoxifen;   Drug: Anastrozole;   Drug: Degarelix;   Drug: Abemaciclib Sponsors:   Jose Pablo Leone;   Eli Lilly and Company;   Translational Breast Cancer Research Consortium (TBCRC) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 15, 2022 Category: Research Source Type: clinical trials

CYP2D6 Genotypes and Breast Cancer Clinical Outcomes in the Indonesian Population
Condition:   Breast Cancer Intervention:   Drug: Tamoxifen Sponsors:   Nalagenetics Pte Ltd;   SJH Initiatives;   Fakultas Farmasi Universitas Indonesia;   MRCCC Siloam Hospitals Semanggi Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 15, 2022 Category: Research Source Type: clinical trials

ETHAN - ET for Male BC
Conditions:   Male Breast Cancer;   Hormone Receptor-positive Breast Cancer;   Hormone Receptor Negative Breast Carcinoma Interventions:   Drug: Tamoxifen;   Drug: Anastrozole;   Drug: Degarelix;   Drug: Abemaciclib Sponsors:   Jose Pablo Leone;   Eli Lilly and Company;   Translational Breast Cancer Research Consortium (TBCRC) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 15, 2022 Category: Research Source Type: clinical trials